Mono-allelic and bi-allelic ENPP1 deficiency promote post-injury neointimal hyperplasia associated with increased C/EBP homologous protein expression

Atherosclerosis

Volumn 233, Issue 2, 2014, Pages 493-502

  Serrano, Ramon L ^a   Yu, Weifang ^a   Terkeltaub, Robert ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Artery media calcification; CHOP; ER stress; Generalized arterial calcification of infancy; Unfolded protein response

Indexed keywords

ALKALINE PHOSPHATASE; C EBP HOMOLOGOUS PROTEIN; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; PHOSPHODIESTERASE I; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; ALKALINE PHOSPHATASE 2, MOUSE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INORGANIC PYROPHOSPHATASE; PHOSPHODIESTERASE; RUNX2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CALCIFICATION; ARTERY MEDIA; ARTERY MEDIA CALCIFICATION; ARTICLE; ATHEROSCLEROSIS; BI ALLELIC ENPP1 DEFICIENCY; BIOLOGICAL ACTIVITY; C57BL 6 MOUSE; CAROTID ARTERY; CAROTID ARTERY INJURY; CAROTID ARTERY LIGATION; CELL MIGRATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME DEFICIENCY; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MONO ALLELIC ENPP1 DEFICIENCY; MOUSE; NEOINTIMAL HYPERPLASIA; NONHUMAN; OSSIFICATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNFOLDED PROTEIN RESPONSE; WESTERN BLOTTING; ALLELE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CAROTID ARTERY OBSTRUCTION; CELL DIFFERENTIATION; DEFICIENCY; DISEASE MODEL; GENETICS; GENOTYPE; INTIMA; LIGATION; METABOLISM; NEOINTIMA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SMOOTH MUSCLE FIBER; TUNICA MEDIA; VASCULAR CALCIFICATION;

ALKALINE PHOSPHATASE; ALLELES; ANIMALS; CAROTID STENOSIS; CELL DIFFERENTIATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DISEASE MODELS, ANIMAL; GENOTYPE; HYPERPLASIA; LIGATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; PHOSPHORIC DIESTER HYDROLASES; PYROPHOSPHATASES; TRANSCRIPTION FACTOR CHOP; TUNICA INTIMA; TUNICA MEDIA; UNFOLDED PROTEIN RESPONSE; VASCULAR CALCIFICATION;

EID: 84896269461     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.01.003     Document Type: Article

References (35)

1. Shanahan C.M., Crouthamel M.H., Kapustin A., Giachelli C.M. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 2011, 109:697-711.
2. Bostrom K.I., Rajamannan N.M., Towler D.A. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res 2011, 109:564-577.
3. Shao J.S., Sierra O.L., Cohen R., et al. Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis. Arterioscler Thromb Vasc Biol 2011, 31:1821-1833.
4. Sutliff R.L., Walp E.R., El-Ali A.M., Elkhatib S., Lomashvili K.A., O'Neill W.C. Effect of medial calcification on vascular function in uremia. Am J Physiol Renal Physiol 2011, 301:F78-F83.
5. Nitschke Y., Baujat G., Botschen U., et al. Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet 2012, 90:25-39.
6. Rutsch F., Ruf N., Vaingankar S., et al. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification. Nat Genet 2003, 34:379-381.
7. Polewski M.D., Johnson K.A., Foster M., Millan J.L., Terkeltaub R. Inorganic pyrophosphatase induces type I collagen in osteoblasts. Bone 2010, 46:81-90.
8. Terkeltaub R. Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification. Purinergic Signal 2006, 2:371-377.
9. -/- mice. Arterioscler Thromb Vasc Biol 2005, 25:686-691.
10. Tasaki T., Yamada S., Guo X., et al. Apoptosis signal-regulating kinase 1 deficiency attenuates vascular injury-induced neointimal hyperplasia by suppressing apoptosis in smooth muscle cells. Am J Pathol 2013, 182:597-609.
11. Dammanahalli K.J., Stevens S., Terkeltaub R. Vanin-1 pantetheinase drives smooth muscle cell activation in post-arterial injury neointimal hyperplasia. PLoS One 2012, 7:e39106.
12. Nadra I., Boccaccini A.R., Philippidis P., et al. Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages. Atherosclerosis 2008, 196:98-105.
13. Johnson K.A., Yao W., Lane N.E., Naquet P., Terkeltaub R.A. Vanin-1 pantetheinase drives increased chondrogenic potential of mesenchymal precursors in ank/ank mice. Am J Pathol 2008, 172:440-453.
14. -/- mice. JVasc Res 2011, 48:227-235.
15. Sakaguchi T., Yan S.F., Yan S.D., et al. Central role of RAGE-dependent neointimal expansion in arterial restenosis. JClin Invest 2003, 111:959-972.
16. Yu W., Liu-Bryan R., Stevens S., Dammanahalli J.K., Terkeltaub R. RAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activity. Atherosclerosis 2012, 222:417-425.
17. Adamopoulos C., Farmaki E., Spilioti E., Kiaris H., Piperi C., Papavassiliou A.G. Advanced glycation end-products induce endoplasmic reticulum stress in human aortic endothelial cells. Clin Chem Lab Med 2013, 2:1-10.
18. Marciniak S.J., Yun C.Y., Oyadomari S., et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 2004, 18:3066-3077.
19. -/- mice lacking CHOP. Cell Metab 2009, 9:474-481.
20. Gao J., Ishigaki Y., Yamada T., et al. Involvement of endoplasmic stress protein C/EBP homologous protein in arteriosclerosis acceleration with augmented biological stress responses. Circulation 2011, 124:830-839.
21. Shirakawa K., Maeda S., Gotoh T., et al. CCAAT/enhancer-binding protein homologous protein (CHOP) regulates osteoblast differentiation. Mol Cell Biol 2006, 26:6105-6116.
22. Pereira R.C., Stadmeyer L., Marciniak S.J., Ron D., Canalis E. C/EBP homologous protein is necessary for normal osteoblastic function. JCell Biochem 2006, 97:633-640.
23. Pereira R.C., Stadmeyer L.E., Smith D.L., Rydziel S., Canalis E. CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia. Bone 2007, 40:619-626.
24. Patsouris D., Neels J.G., Fan W., Li P.P., Nguyen M.T., Olefsky J.M. Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage chemotaxis and recruitment. JBiol Chem 2009, 284:31223-31235.
25. Gregory C.A., Gunn W.G., Peister A., Prockop D.J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004, 329:77-84.
26. Masuda M., Miyazaki-Anzai S., Levi M., Ting T.C., Miyazaki M. PERK-eIF2α-ATF4-CHOP signaling contributes to TNFα-induced vascular calcification. JAm Heart Assoc 2013, 2:e000238.
27. Dai X.Y., Zhao M.M., Cai Y., et al. Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release. Kidney Int 2013, 83:1042-1051.
28. B'chir W., Maurin A.C., Carraro V., et al. The eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression. Nucleic Acids Res 2013, 41:7683-7699.
29. Bacci S., Rizza S., Prudente S., et al. The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients. Diabetes 2011, 60:1000-1007.
30. Eller P., Hochegger K., Feuchtner G.M., et al. Impact of ENPP1 genotype on arterial calcification in patients with end-stage renal failure. Nephrol Dial Transplant 2008, 23:321-327.
31. Bacci S., Di Paola R., Menzaghi C., et al. ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol 2009, 29:1678-1683.
32. Zhao G., Xu M.J., Zhao M.M., et al. Activation of nuclear factor-kappa B accelerates vascular calcification by inhibiting ankylosis protein homolog expression. Kidney Int 2012, 82:34-44.
33. i-generating enzyme PC-1 in human chondrocytes. Proc Natl Acad Sci U S A 1995, 92:10364-10368.
34. O'Neill W.C., Sigrist M.K., McIntyre C.W. Plasma pyrophosphate and vascularcalcification in chronic kidney disease. Nephrol Dial Transplant 2010, 25:187-191.
35. Riser B.L., Barreto F.C., Rezg R., et al. Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia. Nephrol Dial Transplant 2011, 26:3349-3357.